Tech Company Financing Transactions
Cellpoint Diagnostics Funding Round
Mohr Davidow Ventures and Northgate Capital participated in a $11.2 million Series A funding round for Cellpoint Diagnostics. The round was announced on 10/15/2007.
Transaction Overview
Company Name
Announced On
10/15/2007
Transaction Type
Venture Equity
Amount
$11,220,000
Round
Series A
Proceeds Purpose
The capital is supporting operations, the advancement of the technology platform into product development, and early clinical research efforts. This is a second close of its series A round.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
265 N Whisman Rd.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
CellPoint Diagnostics is an early stage company developing diagnostic, monitoring, and molecular analytical tools for cancer. Our novel, proprietary technology captures and analyzes circulating tumor cells (CTCs) directly from patient blood.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Lee Aurich
President
Anne Sill
Vice President
Lena Wu
VP - Engineering
Lou Dietz
Browse more venture capital transactions:
Prev: 10/15/2007: MediKeeper venture capital transaction
Next: 10/15/2007: Tengion venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs